S-allylmercaptocysteine Improves NAFLD by Enhancing AhR/Nrf2-mediated Drug Metabolising Enzymes and Reducing NF-κB/IκBα and NLRP3/6-mediated Inflammation

Accession: GSE150841
Source / host: GEO — NCBI GEO FTP
Disease relevance: MASLD / NAFLD / NASH (category: Transcriptomic, subtype: bulk RNA-seq)
Modality / assay: bulk-RNAseq
Platform: Expression profiling by high throughput sequencing, 23945
Organism: rat
Samples: 12
Size (indexed): (None bytes)
Downloaded bytes: 3.8 MB (3955480 bytes)
Access / raw: public /

Download

Files

FileSizeSHA256
GSE150841_gene_exp.txt.gz3.8 MBbefa1f2981b7fbda…

Crawled by masld-atlas-crawler v1.0 at 2026-08-06T08:27:00Z.

About this dataset

This Expression profiling by high throughput sequencing, 23945 dataset provides single-cell gene expression from rat liver samples, with disease state recorded as MASLD/NAFLD/NASH. It profiles about 12 cells or nuclei.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.